Health3 months ago
Citius Pharmaceuticals Shares Surge 22% After Launch of LYMPHIR Therapy
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) experienced a significant surge of 22.12% in after-hours trading on Tuesday, closing at $1.27. This increase follows the company’s fiscal year 2025...